현재 위치: > 사전 1> 10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-

10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-

상품명칭: 10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-
CAS 레지스트리 번호: 56092-81-0
동의어: 10,16-Docosadienoic acid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[octahydro-5'-(1-hydroxyethyl)-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,[2S-[2a[2'S*,5'R*(S*)],5b(4S*,6R*,8R*,10Z,12S*,14S*,16E,18S*,19S*,20R*,21R*)]]-;SQ 23377;Ionomycin;10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-; [2S-[2a[2'S*,5'R*(S*)],5b(4S*,6R*,8R*,10Z,12S*,14S*,16E,18S*,19S*,20R*,21R*)]]-11,19,21-Trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[octahydro-5'-(1-hydroxyethyl)-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-10,16-docosadienoicacid;
분자 구조:
분자식: C41H72 O9
분자량: 709.005
밀도:  1.072 g/cm3
비등점:  817.2 °C at 760 mmHg
굴절률:  1.512
위험 코드:  22
안전 문장:  36
위험 기호:  Xn: Harmful;

기타 제품